| Autor: |
Kurz KS; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany., Noerenberg D; Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin, Berlin, Germany., Schaich M; Klinik für Hämatologie, Onkologie und Palliativmedizin, Rems-Murr-Klinikum Winnenden, Winnenden, Germany., Bethge W; Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Horn H; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany., Staiger AM; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Damm F; Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin, Berlin, Germany., Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. |
Plný text